Navigation Links
Human, Porcine Endothelin-1 , 125I Conjugated/Tagged from PerkinElmer

ProductsHuman, Porcine Endothelin-1 , 125I Conjugated/Tagged from PerkinElmer
Company PerkinElmer
Item Human, Porcine Endothelin-1 , 125I Conjugated/Tagged
Price 
Description Radiochemical Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related research has long been enabled by the continual availability of new radiolabeled ligands selected to keep pace with new discoveries. PerkinElmer offers a wide range of products and services for receptor research and drug discovery, including over 400 state-of-the-art radioligands. If you do not find exactly what you need, we invite you to take advantage of our custom labeling services, in which we will work with you, scientist to scientist, to prepare the custom radiolabeled ligand that meets your specifications.\n\nWarning\n\nThis product contains a chemical (s) known to the state of California to cause cancer. This product also contains a component which is harmful by contact, ingestion and inhalation. It is irritating to the eyes, skin and respiratory tract, is toxic and flammable. Target organs are the central nervous system, respiratory system, kidneys and liver.\n
Info PerkinElmerPerkinElmer
PerkinElmer Life & Analytical Sciences.
710 Bridgeport Avenue
Shelton, CT 06484-4794, USA





Call PerkinElmer to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-823-5510
Customer Service: (800) 762-4000; Outside the USA: (+1) 203-925-4602
Fax Number: (203) 944-4904
Web Site: http://www.perkinelmer.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Human, Porcine Endothelin-1 , 125I Conjugated/Tagged from PerkinElmer
2. Smac/DIABLO, Human, Recombinant, E. coli from Calbiochem
3. Human, Porcine Endothelin-1 from Biotrend Chemikalien GmbH
4. Human, Bovine, Porcine, Rat VIP, aa 6-28 from Biotrend Chemikalien GmbH
5. Porcine Leptin ELISA Kit from Diagnostic Systems Laboratories, Inc.
6. Porcine Galanin , 125I Conjugated/Tagged from PerkinElmer
7. Porcine Galanin , 125I Conjugated/Tagged from PerkinElmer
8. Porcine Neuromedin U-25 , 125I Conjugated/Tagged from PerkinElmer
9. Porcine Neuromedin U-25 , 125I Conjugated/Tagged from PerkinElmer
10. Porcine Angiotensin Converting Enzyme from BIOPUR
11. Mouse Anti-Porcine Pyruvate Dehydrogenase (PDH), complex Immunocapture Kit Monoclonal Antibody, Protein G-Agarose Conjugated, Clone 15D3G9C11 from MitoScience LLC
... Anti-NY-ESO-1, clone E978 ... : NM_001327 Immunogen ... protein Formulation: mouse ascites ... Quality Assurance: routinely evaluated ...
... to Opsin 1 ( Abpromise for all ... peptide: YEDSTHASIFTYT, corresponding to amino acids 14/26 of ... corresponding to amino acids 18/30 of tiger red ... immunogen. Entrez Gene ID: ...
Goat polyclonal to p27 KIP 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-KRPATDDS STQNK, corresponding to Internal sequence amino acids 153-165 of Human p27 KIP 1 ...
Request Info...
Biology Products:
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 30, 2015 after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
(Date:7/9/2015)... July 9, 2015  Unchained Labs just can,t ... acquisition of Avid Nano. Avid Nano designs, develops ... systems.    Also today, Unchained Labs ... easiest to use protein sizing system. The pUNk ... protein,s hydrodynamic size, size distribution, aggregation population and ...
(Date:7/8/2015)... , July 8, 2015 Summary ... and the fourth most fatal, with a mortality rate ... poor prognosis of pancreatic cancer patients has highlighted a ... which is not being met by the current market. ... array of products with varying molecule types and mechanisms ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... When investigating cancer cells, researchers discovered numerous peculiarities: ... genes are overactive. Do these characteristics have a relation ... inactivate growth brakes or are they just a whim ... scientists perform what are called loss-of-function analyses. They knock ...
... the University of Hawaii Cancer Center and The Queen,s ... from the National Cancer Institute to develop novel methods ... analysis of gene expression and imaging data of the ... a research scientist at the UH Cancer Center, and ...
... An extreme form of pregnancy-related nausea and vomiting known ... of women each year and can lead to hospitalization and ... the only victims. A joint study by ... children whose mothers suffered from HG while carrying them were ...
Cached Biology News:A question of gene silencing 2Hawaii receives funding for liver cancer research 2Extreme morning sickness could lead to lifelong emotional, behavioral disorders in kids 2
(Date:7/28/2015)... NEW YORK , July 28, 2015 ... "Company"), a diversified life sciences company, today announced that ... authorized shares of common stock of the Company from ... held on July 27, 2015 at the Law Offices ... Meeting").   At the Special Meeting, there were 480,655,929 shares ...
(Date:7/28/2015)... , July 28, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that it has granted to German life sciences ... development and commercialization of biotechnology (collectively, the "Optionee"), ... oral allogenic tumor vaccine technology (the "Technology"), including ... cancer which is ready to enter a Phase ...
(Date:7/27/2015)... FRANKLIN, Tenn. , July 27, ... provider of health care services and one of ... today announced that its parent company and sole ... agreement with Medical Properties Trust, Inc. ("MPT") (NYSE: ... for $900 million in cash.  The transaction is expected to ...
(Date:7/27/2015)... MONTREAL , July 27, 2015   ... that produces sustainable biological accelerators for farmers, has ... Patent and Trademark Office for its patent application ... that accelerate plant growth and enhance yields on ... patent relates to Inocucor,s live IN-M1 microbial consortium ...
Breaking Biology Technology:Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5Inocucor Technologies Receives Groundbreaking U.S. Patent for Proprietary Biological Processes that Stimulate Plant Growth 2Inocucor Technologies Receives Groundbreaking U.S. Patent for Proprietary Biological Processes that Stimulate Plant Growth 3